SCHEMBL24699674

SCHEMBL24699674

c1ccc(-c2ccc(N(c3c(-c4ccccc4)ccc4ccc(-c5ccccc5)cc34)c3ccc4ccc5c(N(c6ccc(-c7ccccc7)cc6-c6ccccc6)c6c(-c7ccccc7)ccc7ccc(-c8ccccc8)cc67)ccc6ccc3c4c65)c(-c3ccccc3)c2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLG P00747 1/20 0.36
PLAU P00749 1/20 0.36
CDK4 P11802 2/20 0.33
CCND1 P24385 2/20 0.33
HSD17B1 P14061 1/20 0.33
HSD17B2 P37059 1/20 0.33
MEN1 O00255 1/20 0.33
APAF1 O14727 1/20 0.33
NPC1 O15118 1/20 0.33
LMNA P02545 1/20 0.33
MAPT P10636 1/20 0.33
THRB P10828 1/20 0.33
XBP1 P17861 1/20 0.33
PTBP1 P26599 1/20 0.33
HTT P42858 1/20 0.33
RAB9A P51151 1/20 0.33
GALK1 P51570 1/20 0.33
BLM P54132 1/20 0.33
SMAD3 P84022 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21473895 0.93 CDK4 (0.32) PLGPLAUCDK4CCND1
SCHEMBL21475616 0.90 PLG (0.36) PLGPLAUCDK4CCND1HSD17B1
SCHEMBL24699673 0.89 PLG (0.33) PLGPLAUCDK4CCND1
SCHEMBL21473896 0.87 CDK4 (0.34) PLGPLAUCDK4CCND1
SCHEMBL21475598 0.85 PLG (0.33) PLGPLAUCDK4CCND1HSD17B1
SCHEMBL21475597 0.84 PLG (0.33) PLGPLAUCDK4CCND1
SCHEMBL15461331 0.83 HSD17B1 (0.36) PLGPLAUCDK4CCND1HSD17B1
SCHEMBL18810731 0.83 HSD17B1 (0.36) PLGPLAUCDK4CCND1HSD17B1
SCHEMBL24699017 0.83 ALDH1A1 (0.33) MEN1LMNAMAPTTHRBKMT2A
SCHEMBL24699688 0.82 PRKDC (0.34) PLGPLAULMNABLMSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11512039-B2 Aromatic amine derivatives, preparation methods therefor, and uses thereof GUANGZHOU CHINARAY OPTOELECTRONIC MATERIALS LTD. (CN) 2022-11-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11512039-B2 Aromatic amine derivatives, preparation methods therefor, and uses thereof SLC7A1, WEE1, SLC7A5 PLG 3503/4885PLAU 3740/4885CDK4 2113/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.